| Pharmaceutical Information |
| Drug Name |
Pentazocine hydrochloride |
| Drug ID |
BADD_D01719 |
| Description |
The first mixed agonist-antagonist analgesic to be marketed. It is an agonist at the kappa and sigma opioid receptors and has a weak antagonist action at the mu receptor. (From AMA Drug Evaluations Annual, 1991, p97) |
| Indications and Usage |
For the relief of moderate to severe pain. |
| Marketing Status |
Discontinued; Prescription |
| ATC Code |
N02AD01 |
| DrugBank ID |
DB00652
|
| KEGG ID |
D02227
|
| MeSH ID |
D010423
|
| PubChem ID |
441277
|
| TTD Drug ID |
D0W6DG
|
| NDC Product Code |
48087-0077; 63190-0050; 17337-0028 |
| Synonyms |
Pentazocine | Lexir | Pentazocine Lactate | Lactate, Pentazocine | Talwin | Fortral | Pentazocine Hydrochloride | Hydrochloride, Pentazocine |
|
| Chemical Information |
| Molecular Formula |
C19H28ClNO |
| CAS Registry Number |
64024-15-3 |
| SMILES |
CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O.Cl |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Cardiovascular insufficiency | 24.06.03.005; 02.01.01.011 | - | - | Not Available |
|
|
|
